MSCI USA IMI Biotech Advance Index

The MSCI USA IMI Biotech Advance Index aims to represent the performance of a set of companies across large, mid and small cap representation in the US market, that are associated with research, development, and commercialization of products for treating a broad range of diseases and disorders.
Get in touch
Document downloads
Index code
753365
Index type
Equity
Benchmark administrator
--
Div Yld (%)
0.87
P/E
91.28
P/E Fwd
41.33
P/BV
5.16
Number of constituents
83
Index Market Cap
$1.97 T
Largest constituent Market Cap
$199.06 B
Smallest constituent Market Cap
$1.26 B
Average constituent Market Cap
$23.78 B
Median constituent Market Cap
$6.32 B
Does this benchmark pursue ESG objectives?
No
Data as of July 31, 2025 

Want to learn more about MSCI indexes?
Get in touch.

Contact us